Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging
Pleura and Peritoneum · 08.06.2021 · 6 (2) · 67-74
DOI: 10.1515/pp-2020-0149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pleura and Peritoneum, online erschienen am 24.03.2021. Verfasst von Marion Larroque und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institut du Cancer de Montpellier, Unité de Recherche Translationnelle, Montpellier, France. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aquitaine Region and FEDER.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
Platinum salts are commonly used in hyperthermic intraperitoneal chemotherapy (HIPEC) for digestive tract cancer treatment. During HIPEC with oxaliplatin for peritoneal metastases (PMs) treatment, the ovaries are directly exposed to the drug, questioning about ovarian resection and the potential impact of the drug on ovarian functionality, especially in young women of childbearing age. The goal of this work is to understand unwanted damages to the ovaries during HIPEC therapy by the determination of the concentration and distribution of platinum in ovaries in order to address its potential toxicity.
Methods
Mass spectrometry imaging techniques, matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP MS), were used to study the penetration of oxaliplatin in ovaries after HIPEC treatment.
Results
MALDI-MS allowed the localization of an oxaliplatin-derivative ( m/z 456.2) at the periphery of the ovaries. The quantitative LA-ICP MS maps confirmed the localization of elemental platinum as well as in the central part of ovaries from patients who received a previous platinum salt-based chemotherapy.
Conclusions
LA-ICP MS images showed that platinum diffusion was extended in cases of previous systemic treatment, questioning about platinum derivatives gonado-toxicity when combining the two treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut du Cancer de Montpellier, Unité de Recherche Translationnelle, Montpellier, France.
- IRCM, INSERM, Univ Montpellier, Montpellier, France.
- Universite de Pau et des Pays de l'Adour, E2S UPPA, CNRS, IPREM, Pau, France.
- Département Chirurgie Oncologique, Institut du Cancer de Montpellier, Montpellier, France.
- Département d'Anatomopathologie, Institut du Cancer de Montpellier, Montpellier, France.
- Centre des Ressources Biologiques, Institut du Cancer de Montpellier, Montpellier, France.
ORCID-Profile: Sandra Mounicou, Olivia Sgarbura
Förderung
- Aquitaine Region and FEDER
Zitieren
APA
Larroque, M., Mounicou, S., Sgarbura, O., Arnaudguilhem, C., Rebel, L., Leaha, C., Faye, P. A., Enjalbal, C., Quénet, F., Bouyssiere, B., & Carrere, S. (2021). Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging. Pleura and Peritoneum, 6(2), 67-74. https://doi.org/10.1515/pp-2020-0149
Vancouver
Larroque M, Mounicou S, Sgarbura O, Arnaudguilhem C, Rebel L, Leaha C, et al. Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging. Pleura and Peritoneum. 2021;6(2):67-74. doi:10.1515/pp-2020-0149
BibTeX
@article{Larroque2021,
author = {Larroque, Marion and Mounicou, Sandra and Sgarbura, Olivia and Arnaudguilhem, Carine and Rebel, Lucie and Leaha, Cristina and Faye, Pierre-Arnaud and Enjalbal, Christine and Quénet, François and Bouyssiere, Brice and Carrere, Sébastien},
title = {Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging},
journal = {Pleura and Peritoneum},
year = {2021},
volume = {6},
number = {2},
pages = {67--74},
doi = {10.1515/pp-2020-0149}
}
EUVIMED